Stuart Grant
General Counsel bei NUCANA PLC
Profil
Stuart Grant is currently the Vice President of Regulatory Affairs at NuCana Plc since 2018.
Prior to this, he worked as an Associate Director of Regulatory Affairs at ClinTec International Ltd.
Dr. Grant received his undergraduate and doctorate degrees from the University of Strathclyde.
Aktive Positionen von Stuart Grant
| Unternehmen | Position | Beginn |
|---|---|---|
| NUCANA PLC | General Counsel | 01.09.2018 |
Ehemalige bekannte Positionen von Stuart Grant
| Unternehmen | Position | Ende |
|---|---|---|
ClinTec International Ltd.
 ClinTec International Ltd. Personnel ServicesCommercial Services ClinTec International Ltd. provides clinical research personnel and support services. Its services include full service outsourcing, functional service provider solutions, patient recruitment and retention, education and training, clinical supplies and packaging. The firm offers therapeutics for cardiovascular disease, dermatology, endocrine and metabolic disorders, gastrointestinal disease, genetic disorders, hematology, hepatobiliary, immunology, infectious diseases, nephrology, neurology, nutrition, oncology and orthopedics. The company was founded by Rabinder Buttar in 1997 and is headquartered in Glasgow, the United Kingdom. | Corporate Officer/Principal | - |
Ausbildung von Stuart Grant
| University of Strathclyde | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NUCANA PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
ClinTec International Ltd.
ClinTec International Ltd. Personnel ServicesCommercial Services ClinTec International Ltd. provides clinical research personnel and support services. Its services include full service outsourcing, functional service provider solutions, patient recruitment and retention, education and training, clinical supplies and packaging. The firm offers therapeutics for cardiovascular disease, dermatology, endocrine and metabolic disorders, gastrointestinal disease, genetic disorders, hematology, hepatobiliary, immunology, infectious diseases, nephrology, neurology, nutrition, oncology and orthopedics. The company was founded by Rabinder Buttar in 1997 and is headquartered in Glasgow, the United Kingdom. | Commercial Services |
